Conversations in Drug Development Trends
FEBRUARY 21, 2024
During clinical development, new chemical entities (NCEs) require an absorption, metabolism, and excretion (AME) study. As a result, we ensure collection of all urine and fecal samples over a period ranging between five to seven days, modifying the participant diet if needed.
Cytel
JUNE 19, 2024
Historically, many drugs have been prescribed to children even though this patient population have largely been excluded from clinical trials. There is an obvious logic. If medicines are to be used in children, they need to be studied in pediatric populations to ensure they are safe and effective.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 10, 2020
Growing into a biopharmaceutical company, Innovent has built an integrated platform covering from drug discovery, CMC, clinical development and commercialization. Michael Yu reviewed the history and achievements in the past nine years since the establishment of Innovent.
The Pharma Data
JUNE 11, 2025
The Broad Institute, one of the world’s leading biomedical research centers, brings deep capabilities in genomics, systems biology, and computational analytics. Bayer contributes decades of experience in pharmaceutical R&D, encompassing drug design, medicinal chemistry, and clinical development for both small molecules and biologics.
Drug Target Review
FEBRUARY 11, 2025
Addressing the long timelines and high costs of drug development is therefore critical for the advancement of medical innovation. Unfortunately, many drug candidates fail. Clinical development failure may be due to an inability to demonstrate efficacy or sufficient safety. Unfortunately, many drug candidates fail.
Expert insights. Personalized for you.
80 
Let's personalize your content